baber/WOPTO huggingface dataset:
Patent AU-4610599-A (AU)
Title: Alpha-amylase resistant polysaccharides, production method and use thereof and food products containing said polysaccharides
Inventor: BENGS HOLGER
IPC: A23L29/30
Filed: 1999-06-15
Abstract: The invention relates to a production method of alpha-amylase resistant polysaccharides with high RS content, comprising the following steps: a) producing a paste of water-insoluble poly-(1,4-alpha-D-glucan) and water; b) heating the paste; c) cooling off and retrogradation of the past at a temperature that is lower than the temperature of the heated paste and d) optionally drying the resulting product.
Patent AU-4776399-A (AU)
Title: Benflumetol derivatives, intermediates thereof and their use against parasiticalprotozoa and trematodes
Inventor: WERNSDORFER WALTHER HELMUT
IPC: C07C217/08
Filed: 1999-06-23
Abstract: The invention relates to a compound of formula (I),wherein R is an alkyl unsubstituted by one or more polar substituents or an alkenyl unsubstituted or substituted by one or more polar substituents, and X is aryl, or salts thereof. The compounds are effective e.g. against protozoa and trematodes.
Patent AU-4840193-A (AU)
Title: Oligonucleotide modulation of cell adhesion
Inventor: BENNET C FRANK
IPC: C07H21/02
Filed: 1993-08-27
Abstract: Compositions and methods are provided for the treatment and diagnosis of diseases amenable to treatment through modulation of the synthesis or metabolism of intercellular adhesion molecules. In accordance with preferred embodiments, oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial leukocyte adhesion molecule-1. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a transcription initiation site, a translation initiation site, 5'-untranslated sequences, 3'-untranslated sequences, and intervening sequences. Methods of treating animals suffering from disease amenable to therapeutic intervention by modulating cell adhesion proteins with an oligonucleotide specifically hybridizable with RNA or DNA corresponding to one of the foregoing proteins are disclosed. Methods for treatment of diseases responding to modulation cell adhesion molecules are disclosed.
Patent AU-4870099-A (AU)
Title: Noncoherent gain enhancement technique for improved detection-estimation performance
Inventor: DAVID GEORGE T
IPC: G01S7/292
Filed: 1999-07-12
Abstract: A system and method of processing data in a sensor system which receives signal returns from pulsed coherent transmitted signals which are transmitted at a pulse repetition rate and with a pulse repetition interval (PRI). The method includes providing range-filtered data in response to the received signal returns; formatting successive sets of data received during a post detection integration (PDI) interval into a plurality of overlapping coherent processing interval (CPI) data sequences; performing FFT processing on the overlapping CPI data sequences to provide transformed data sequences; performing range-sample CPI processing on the transformed data sequences; and performing noncoherent integration (NCI) processing on output data from the range-sample CPI processed data sequences over a range trajectory in accordance with hypothesized radar-target range rate to provide noncoherent gain-enhanced output data. A range trajectory derived from a hypothesized radar-target range rate is updated at a compensation rate no more often than once per PDI interval.
Patent AU-4873600-A (AU)
Title: Clavicle bandage
Inventor: HERZBERG THORSTEN
IPC: A61F5/058
Filed: 2000-07-20
Abstract: The clavicle bandage (1) comprises two straps (2) which have adjustable lengths and are made of an inextensible material, with means (5) at their ends for formation of loops attached to a ring (3) with a flat elliptical cross section. The bandage is provided with a cloth pocket which fixes the position and orientation of the straps relative to one another.
Patent AU-4916597-A (AU)
Title: Semi-synthetic studies toward didemnin analogues
Inventor: RINEHART KENNETH L
IPC: C07K5/027
Filed: 1997-10-24
Abstract: Disclosed are semi-synthetic methods for the preparation of Didemnin Analogs. The compounds of this type are illustrated in Formula (I).
Patent AU-5047185-A (AU)
Title: Lubricant additive comprising a molybdenum tertiary amine complex
Inventor: SCHREIBER HANS
IPC: C10M159/18
Filed: 1985-11-28
Abstract: The present invention provides a lubricant additive obtainable by the reaction of a salt of a tertiary amine, which, as N-substituents, contains two polyethylene oxide residues with two or more ethylene oxide groups, the free hydroxyl groups of which can be etherified or acylated, and one saturated or unsaturated long-chain alkyl radical, with ammonium molybdate and/or MoO3.
Patent AU-5073500-A (AU)
Title: Coupling and a piston for use in the same
Inventor: HEIJDEN LAMBERTUS GERARDUS DER
IPC: B67D1/08
Filed: 2000-05-26
Abstract: A piston for use in a coupling for a liquid product packaging and dispensing assembly in which liquid is pumped from a container via the coupling through a tube to the point of use. Such a coupling comprises a first interconnectable member with a hollow post and a biased sleeve closing openings in the hollow post and a second interconnectable member with a hollow sheath and a biased piston closing an opening at the end of the sheath. The parts are configured so that, upon connection, the post unseats the piston while the sheath displaces the sleeve, thereby allowing liquid flow. The piston is gas permeable and liquid impermeable. It and the post are configured such that, upon connection, any fluid residing between them is displaced. <IMAGE>
Patent AU-5153399-A (AU)
Title: Stabilised compositions having antibacterial activity
Inventor: PEDERSEN LARS HAASTRUP
IPC: A61L15/44
Filed: 1999-08-13
Abstract: A stabilised composition having antibacterial, antiviral and/or antifungal activity characterised in that it comprises a silver compound and that the compound is in the form of a complex with a primary, secondary or tertiary amine which complex is associated to one or more hydrophilic polymers is stable during sterilisation and retaining the activity without giving rise to darkening or discoloration of the dressing during storage.
Patent AU-5232090-A (AU)
Title: Opacified molded product and process for producing the same
Inventor: KURODA TAKASHI
IPC: C08J5/18
Filed: 1990-03-28
Abstract: An opacified stretched molded product has a total light transmittance of 50% or less and a density of 0.89 or less and comprimises a composition containing 100 parts by weight of polypropylene and 3 to 40 parts by weight of a cyclopentadiene petroleum resin, said molded product being a product stretched in at least one direction. The invention also provides a resin composition comprising 100 parts by weight of a crystallline polypropylene and 30 to 40 parts by weight of a copolymer resin comprising a copolymer of a cyclopentadiene compound and an aromatic hydrocarbon or a hydrogenated product thereof, and a stretched molded product therefrom. The invention also provides processes for producing the opacified molded products.
Patent AU-5288786-A (AU)
Title: Disc drive compatible tape cartridge
Inventor: HENZE RICHARD H
IPC: G11B25/10
Filed: 1986-01-31
Abstract: A tape cartridge is provided which is arranged to utilize the read/write head(s) in a disc drive to read data from and/or write data to the tape (20). The tape cartridge has a section (A) of a size and shape which enables it to be inserted into the disc drive to locate a portion of the tape (20) at a location suitable for exchanging data with the disc drive head(s). The tape cartridge comprises the tape media (20) itself, means (22,23,26,210,211) for registering the tape media with respect to the read/write head(s) of a disc drive, means for feeding the tape media past the read/write head(s) in the disc drive, and means for storing that portion of the tape media which is not currently being fed past the read/write head(s). The tape cartridge may include a transmission (213) that enables it to utilize the disc-drive spindle motor for feeding the tape. In one embodiment, the transmission includes a clutch for enabling the tape feed direction to be reversed.
Patent AU-5315398-A (AU)
Title: Electrical fuse
Inventor: JOLLENBECK ANDRE
IPC: H01H85/165
Filed: 1997-10-31
Abstract: The present invention relates to an electrical fuse element (1) having a substantially ceramic housing and a fusible conductor (3, 4) and to a process for its production. All known fuses of the said type have problems in mass production, in particular in the fixing and fastening of their fusible conductors. The object is therefore to provide a fuse and a process for its production which simplifies the fixing and fastening of fusible conductors and altogether brings about a reduction in cost in comparison with known processes. The object is achieved according to the invention in that a fusible conductor (3, 4) is placed between two green ceramic layers (2, 5) in such a way that it runs at least between mutually opposite end faces of the ceramic layers (2, 5) and this arrangement is pressed and subsequently sintered.
Patent AU-5324000-A (AU)
Title: Heterocyclic aminopyrrolidine derivatives as melatonergic agents
Inventor: TAKAKI KATHERINE S
IPC: C07D405/04
Filed: 2000-06-06
Abstract: There is provided a novel series of heterocyclic aminopyrrolidine compounds of Formula Iwherein R1, R2, R3, R4, W, Z and the wavy bond <CUSTOM-CHARACTER FILE="US06211225-20010403-P00001.TIF" ID="CUSTOM-CHARACTER-00001"> are as defined herein which bind to the human melatonin receptor and therefore are useful as melatonergic agents.
Patent AU-5370799-A (AU)
Title: Fixing element for bone fragments
Inventor: LOB HELKE
IPC: A61B17/68
Filed: 1999-07-20
Abstract: The invention relates to a fixing element for fixing a first bone fragment (5.1), notably an ankle-bone fragment in ankle joint fractures, to a corresponding second bone fragment (5.2). Said element comprises an elongated spreading part (2) and a fixing part (1) which can be introduced into aligned holes (4, 6) in the bone fragments (5.1, 5.2). The fixing part has a proximal first section (1.1) designed to be introduced into the first bone fragment (5.1) and an adjoining distal second section (1.2) designed to be introduced into the second bone fragment (5.2), as well as a hollow cavity (3) extending substantially along its full length. The fixing part (1) is configured such that it can be fully introduced into the holes (4, 6); by proximal introduction of the spreading part (2) into the hollow cavity (3) at right angles to its longitudinal direction can be spread open by wedge action at least in the area of its two ends so as to be joined to the corresponding bone fragment (5.1, 5.2); and after introduction of the spreading part (2) has a greater transverse dimension at the distal end of the second section (1.2) than at the proximal end of said section.
Patent AU-5388500-A (AU)
Title: Polymer
Inventor: MUELLER HORST
IPC: C09D131/04
Filed: 2000-04-20
Abstract: Polymer obtainable by a multistage polymerization process which involves conducting, in a first step, an aqueous-phase polymerization of at least one ethylenically monofunctional compound alone or together with at least one ethylenically difunctional or poly-functional compound together in the presence of a polyesterpolyol, polyurethane and/or polyacrylate; and, in a subsequent step, a reaction of the resulting product with at least one ethylenically monofunctional compound alone or together with at least one ethylenically difunctional or polyfunctional compound; followed by a reaction of the resulting product with a crosslinker; and its use.
Patent AU-5510886-A (AU)
Title: Pyrido (2,3-d) pyrimidin derivatives
Inventor: TAYLOR EDWARD C
IPC: C07D487/04
Filed: 1986-02-24
Abstract: 2,4-Diamino- and 2-amino-4-hydroxy- derivatives of N-(4-[2-(pyrido[2,3-d]pyrimidin-6-yl)alkyl]-benzoyl)-L-glutamic acids, and the corresponding 5,6,7,8- tetrahydro compounds are antineoplastic agents.The compounds are prepared by hydrolytic or hydrogenolytic removal of carboxylic acid protecting groups from the correspondingly protected glutamic acid derivatives. A typical embodiment is N-(4-[2-(2-amino-4-hydroxy-5,6,7,8,-tetrahydropyrido[2-3-d]pyrimidin-6 -yl)-ethyl]benzoyl)-L-glutamic acid.
Patent AU-5763386-A (AU)
Title: Improved transportable structure, apt to build up houses or other dwellings
Inventor: FAGNONI GIOVANNA MARIA
IPC: E04B1/348
Filed: 1986-05-21
Abstract: Transportable structure apt to build up houses and the like, for immediate intervention in case of calamities and for other uses, comprising a supporting framework made up of closed longitudinal frames, floor platform, roof covering and head walls, all of which delimiting a useful volume, and mobile panelings able to form additional side rooms; the mobile panelings are finished by pulltruded elements, which form, at least in part, cylindrical surfaces slidingly cooperating to form the articulations; angle bars are provided at the ends of said structural sections to make up the seats for pins able to prevent said cooperating cylindrical surfaces from incidentally moving away from each other; further angle bars perimetrically complete the panels while seals mounted on the sections co-act with the sections being coupled in the articulation, to ensure the sealing.
Patent AU-5992796-A (AU)
Title: Novel formulation for peptide release
Inventor: WALSH JOHN DESMOND
IPC: A61K38/09
Filed: 1996-06-20
Abstract: A pharmaceutical and/or veterinary formulation comprising deslorelin and an excipient, the formulation being characterised in that, in vitro, it releases deslorelin into phosphate buffered saline, as hereinbefore described, at 37° C. at a rate of about 2-80 mug/day for at least 200 days. The formulation may be used for prevention of reproductive function, particularly in dogs and cats, and for the treatment, particularly in humans, of prostate and breast cancer and other diseases and conditions where suppression of testosterone or estradiol levels is beneficial.
Patent AU-6029899-A (AU)
Title: Accumulated phase measurement using open-loop phase estimation
Inventor: AGRAWAL AVNEESH
IPC: G01S1/04
Filed: 1999-09-08
Abstract: An apparatus and method for generating an accumulated phase measurement of a communications signal over a predetermined time interval. A frequency estimate of the signal is generated; the frequency estimate is then converted to a coarse phase measurement. A phase error is generated based on the frequency estimate; the phase error is then converted to a fine phase measurement. The coarse and fine phase measurements are summed to yield an accumulated phase measurement.
Patent AU-6032299-A (AU)
Title: Enhanced security communications system
Inventor: BASAWAPATNA GANESH
IPC: H04H20/00
Filed: 1999-09-08
Abstract: A telecommunications system for providing telecommunication services to a plurality of users connected to a loop-through cable distribution architecture. The system includes a signal collection and transmission circuit or headend circuit for collecting and transmitting telecommunication signals to the user. In addition, the system comprises a signal distribution system or circuit operatively connected to the signal collection and transmission circuit for receiving and transmitting telecommunication signals therefrom and thereto. The system includes a user or customer interface device operatively connected to an associated signal distribution circuit for both receiving telecommunication signals from the associated signal distribution circuit and transmitting telecommunication signals to the associated signal distribution circuit. The signal distribution circuit is formed by a node having a plurality of output lines and a service module operatively connected to one of the node output lines. The service module further includes a signal splitter having a plurality of output lines, a user service module circuit operatively connected to one of the splitter output lines, and a processor control circuit operatively controlling the service module.
Patent AU-6032498-A (AU)
Title: Pilot based, reversed channel power control
Inventor: WILLENEGGER SERGE
IPC: H04B1/04
Filed: 1998-01-27
Abstract: A novel and improved method for performing transmit power control is described. A signal is transmitted at a transmit power and includes a traffic channel transmitted at a traffic channel transmit power, and a pilot channel transmitting at a pilot channel transmit power. The receive energy of the pilot channel is measured, and compared with a threshold. A power control command is generated and transmitted to the system generating the signal. This determines whether the command is to be applied to either the traffic channel, the pilot channel, or the entire signal. The power of the determined channel(s) is adjusted accordingly.
Patent AU-6337390-A (AU)
Title: Brain derived neurotrophic factor
Inventor: HYMAN CAROLYN
IPC: C07K16/28
Filed: 1990-08-29
Abstract: The present invention relates to nucleic acid sequences encoding brain derived neurotrophic factor (BDNF), as well as BDNF protein produced in quantity using these nucleic acid sequences, as well as fragments and derivatives thereof. In addition, the invention relates to pharmacologic compositions and therapeutic uses of BDNF, having provided, for the first time, the means to generate sufficient quantities of substantially pure BDNF for clinical use. In a specific embodiment, BDNF may be used to promote the survival of substantia nigra dopaminergic neurons and basal forebrain cholinergic neurons, thereby providing a method for treating, respectively, Parkinson's disease and Alzheimer's disease. The invention also relates to antibodies directed toward BDNF or fragments thereof, having provided a method for generating sufficient immunogen. Further, by permitting a comparison of the nucleic acid sequences of BDNF and NGF, the present invention provides for the identification of homologous regions of nucleic acid sequence between BDNF and NGF, thereby defining a BDNF/NGF gene family; the invention provides a method for identifying and isolating additional members of this gene family.
Patent AU-6356890-A (AU)
Title: Method of high-resolution sea bottom prospecting and tuned array of paraboloidal, electroacoustic transducers to carry out such method
Inventor: CANNELLI GIOVANNI BOSCO
IPC: G01V1/157
Filed: 1990-09-14
Abstract: PCT No. PCT/IT90/00075 Sec. 371 Date Feb. 27, 1992 Sec. 102(e) Date Feb. 27, 1992 PCT Filed Sep. 14, 1990 PCT Pub. No. WO91/04501 PCT Pub. Date Apr. 4, 1991.A method of and an apparatus for the high-resolution sea bottom prospecting, in which an electroacoustic paraboloidal transducer is placed into water, the electrodes of which are near the focus of the paraboloid and are connected both to a capacitor bank the capacitance of which may be varied at will and to a supply circuit for the generation of an electroacoustic discharge between said electrodes. As the capacitance varies the delay time between the primary pulse or underwater prospecting pulse and the cavitation pulse is recorded at any discharge, and at the same time dominant frequency of the prospecting signal spectrum is determined. Afterwards capacitance values are set so as to provide both cavitation pulses the contribution of which to the resulting pulse is minimum and a dominant frequency spectrum as broad as possible. The preset capacitance values are assigned to a capacitor array connected each to an electroacoustic paraboloidal transducer dipped in water, the electrodes of which are supplied so as to generate the underwater prospecting pulse.
Patent AU-6391198-A (AU)
Title: Universal safety syringe
Inventor: SIEKMANN MANFRED
IPC: A61M5/315
Filed: 1998-02-04
Abstract: Universal safety syringe having a protective cap, a cylinder, a plunger and a cannula mounted on a cannula base, it being the case that the cannula base is designed such that it can be pushed firmly against a stop in the protective cap, that the protective cap, which can be pushed externally onto a cone, corresponding to a Luer cone, of the cylinder, is provided with a narrowed section, which is provided on the inside of the cap, in front of a recess designed for receiving the cannula base, and delimits the push on travel, that a recess which receives a cannula base is provided with an undercut which prevents the cannula base from being removed in the forward direction, and with an undercut of which the effect can be overcome by the cone being widened from the inside and which is provided for safeguarding the cannula stop from being pushed in unintentionally during insertion of the syringe, and it also being the case that the plunger is designed with a section which widens the cone cylindrically and with a mushroom-shaped plunger head, which comes into pulling contact with the needle stop. A preferred embodiment provides a safeguard against the plunger being unintentionally pushed in too early and too far.
Patent AU-6496180-A (AU)
Title: Hybridoma for producing monoclonal antibodies
Inventor: KUNG P C-H
IPC: C12N15/00
Filed: 1980-12-02
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 10% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF, mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Patent AU-6528698-A (AU)
Title: Cap for a container
Inventor: COORY FREDRICK MICHAEL
IPC: B65D51/28
Filed: 1998-03-12
Abstract: A cap for a container where a drink, made of two components, can be stored or carried with the components stored separately. The components are mixed prior to the consumption of the drink. The cap includes a collar secured to the container and a top which is in two parts. The top is moveable between an open and a closed position. When the top is initially in the open position, a basket between the top and the liquid initially holds the material, which can be a powder or tablet. The top is initially closed to release the seal between the liquid and the material, the drink is shaken, and the top reopened for a passageway from the liquid to the exterior of the cap. A cover is releasably secured over the cap.
Patent AU-6559298-A (AU)
Title: Spinning ring having improved traveler bearing surface
Inventor: BENSON RIO H
IPC: D01H7/60
Filed: 1998-03-17
Abstract: The invention provides spinning rings for textile spinning processes having an improved bearing surface formed of a coating of hard nodular chromium which is applied by an electrodeposition process. The spinning rings of the invention can increase the life of travelers that ride on the spinning ring and can provide for high productivity spinning processes.
Patent AU-6739794-A (AU)
Title: Apparatus for treating gases and particulate solids in a fluid bed
Inventor: HARDIE GREGORY J
IPC: C22B1/10
Filed: 1994-07-12
Abstract: A method for treating gases and solids in a fluid bed, the fluid bed reactor substantially comprising, regarded downstream, a mixing chamber (14), a riser pipe (9) and a cyclone (16) with a solids return pipe (11) to the mixing chamber (14), the gases being introduced into the mixing chamber (14) at a gas rate immediately before the inlet port (4) of the mixing chamber of more than (35) m/sec. <IMAGE>
Patent AU-6804500-A (AU)
Title: Oregano-based therapeutic composition
Inventor: PAPAPRODROMOU ANDREAS D
IPC: A61K9/00
Filed: 2000-07-06
Abstract: A therapeutic composition comprising oregano oil, laurel oil, and myrtle oil useful in alleviating pain and discomfort associated with arthritis, migraines, bronchitis, soft tissue injuries, muscle aches and pains and neck and back pains and strains in humans, as well as upper respiratory, joint and shin ailments in animals.